@misc{indiciaef4ebe0853622,
  title = {Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants},
  author = {Parham, K. A. and Kim, G. N. and Saeedian, N. and Ninkov, M. and Richer, C. G. and Li, Y. and Wu, K. and Rashu, R. and Barr, S. D. and Arts, E. J. and Haeryfar, S. M. M. and Kang, C. Y. and Troyer, R. M.},
  year = {2022},
  doi = {10.1101/2022.07.19.500626},
  url = {https://www.biorxiv.org/content/10.1101/2022.07.19.500626v1},
  note = {Source identifier: 10.1101/2022.07.19.500626}
}